A detailed history of Harfst & Associates, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Harfst & Associates, Inc. holds 5,474 shares of MRK stock, worth $538,313. This represents 0.14% of its overall portfolio holdings.

Number of Shares
5,474
Previous 6,245 12.35%
Holding current value
$538,313
Previous $773,000 19.66%
% of portfolio
0.14%
Previous 0.18%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$111.15 - $128.97 $85,696 - $99,435
-771 Reduced 12.35%
5,474 $621,000
Q2 2024

Aug 01, 2024

SELL
$123.8 - $132.96 $57,690 - $61,959
-466 Reduced 6.94%
6,245 $773,000
Q1 2024

Aug 01, 2024

BUY
$113.24 - $131.95 $759,953 - $885,516
6,711 New
6,711 $885,000
Q4 2023

Feb 07, 2024

SELL
$100.18 - $109.02 $13,724 - $14,935
-137 Reduced 0.85%
15,966 $1.74 Million
Q3 2023

Nov 07, 2023

SELL
$102.95 - $114.33 $7,000 - $7,774
-68 Reduced 0.42%
16,103 $1.66 Million
Q2 2023

Aug 07, 2023

BUY
$108.61 - $118.38 $1.25 Million - $1.36 Million
11,524 Added 247.99%
16,171 $1.87 Million
Q1 2023

May 10, 2023

SELL
$102.94 - $114.86 $2,573 - $2,871
-25 Reduced 0.54%
4,647 $494,000
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $12,678 - $16,255
-145 Reduced 3.01%
4,672 $518,000
Q3 2022

Oct 27, 2022

BUY
$84.53 - $94.96 $53,084 - $59,634
628 Added 14.99%
4,817 $415,000
Q2 2022

Jul 28, 2022

BUY
$83.49 - $94.64 $417 - $473
5 Added 0.12%
4,189 $381,000
Q1 2022

Apr 28, 2022

SELL
$73.51 - $82.4 $14,334 - $16,068
-195 Reduced 4.45%
4,184 $343,000
Q3 2021

Oct 28, 2021

SELL
$71.68 - $78.83 $4,730 - $5,202
-66 Reduced 1.48%
4,379 $328,000
Q2 2021

Aug 11, 2021

SELL
$70.31 - $77.77 $183,298 - $202,746
-2,607 Reduced 36.97%
4,445 $345,000
Q1 2021

May 10, 2021

SELL
$68.86 - $81.11 $124,567 - $146,727
-1,809 Reduced 20.42%
7,052 $543,000
Q4 2020

Jan 25, 2021

BUY
$71.77 - $79.65 $635,953 - $705,778
8,861 New
8,861 $724,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Harfst & Associates, Inc. Portfolio

Follow Harfst & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harfst & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harfst & Associates, Inc. with notifications on news.